+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830969
Description Jump to:
The global nanomedicine market size is expected to reach USD 410.15 billion by 2030, expanding at 11.57% CAGR from 2023 to 2030. The advantages of nanomedicine in numerous healthcare applications, the emergence of novel drug delivery technologies, and the rise in demand for safe and affordable treatments are all contributing to the expansion of the nanomedicine industry.

The adoption of nanomedicines is driven by the rise in the prevalence of chronic diseases like cancer and cardiovascular disease. Additionally, the demand for nanomedicine is expanding due to the growing elderly population, and the increase in patients with high blood pressure, obesity, and other cardiovascular diseases. For instance, as per the American Cancer Society, in 2022, an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths were expected in the U. S. alone.

Furthermore, the need for nanomedicines to cure a wide range of illnesses has increased as a result of the COVID-19 pandemic. The development of new approaches for the detection, diagnosis, and cure of the COVID-19 virus as well as other viral infections was made possible by the development of nanomedicine applications. For instance, in November 2020, BioNtech and Pfizer announced the full results of the phase 3 clinical study for the COVID-19 vaccine. They rapidly manufactured vaccinations for testing and regulatory approval using a known technique for encapsulating therapeutic nucleic acid molecules in lipid nanoparticles. Additionally, due to an increase in activities for research and development for nanomedicines across all regions, fueling the market growth.

The developing technologies for drug delivery are important elements that are expected to accelerate the growth of the global market. Also, it is anticipated that the rising popularity of nanomedicine across a variety of applications will fuel the expansion of the nanomedicine industry. Furthermore, it is predicted that the increase in government funding and support will positively affect market growth in the coming years.

New potential opportunities for the expansion of the nanomedicine industry in the upcoming years will be provided by the rise in the out-licensing of nano drugs and the expansion of healthcare facilities in developing nations. Over the past few decades, the US FDA has authorized the commercialization of about 100 nanomedicine applications and devices. As a result, growing interest in nanotechnology's potential medical use is a notable breakthrough in the medical field and further drives market growth.

The rising investment flow in R&D is also driving the nanomedicine industry growth. For instance, in August 2022, South Korea’s Life Science Fund declared an investment of over USD 14 million (19 billion won) in Senda Biosciences Inc., a U. S.-based biotechnology firm involved in the creation of nanoparticle-based drug delivery products. Such investments indicate promising growth opportunities for the nanomedicine industry in the near future.

Nanomedicine Market Report Highlights

  • By application, the drug delivery segment accounted for the largest share of 34.09% in 2022. The need for cutting-edge treatments for neurological conditions like Parkinson's disease, brain tumors, and Alzheimer's disease is expected to spur additional market expansion for nanomedicine-based drug delivery systems
  • By indication, the clinical oncology segment held the largest share of 32.44% in 2022. The growing prevalence of cancer and the advantages of nanomedicines such as high sensitivity and improved therapeutic efficacy are promoting the segment growth
  • By molecule type, the nanoparticlessegment held the largest share of 76.32% in 2022. The widespread use of metal & metallic oxides and the utilization of nanoparticles in various medical settings is expected to encourage market expansion in the forecasted years
  • North America held the largest share of 49.91% in 2022. This can be attributed to the presence of a significant number of key players, as well as rising healthcare spending and federal assistance in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Level Of Government Participation In R&D Funding
3.2.1.2. Introduction Of Technological Advancements In Diagnostic Procedures
3.2.1.3. Rising Usage Of Nanomedicine In Drug Delivery Technology
3.2.2. Market Restraint Analysis
3.2.2.1. Side Effects Associated With Intake Of Nanoparticles And Lower Adoption Rate By Patients
3.2.2.2. Limited Adoption By Medical And Pharmaceutical Industry
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Application Business Analysis
4.1. Nanomedicine Market: Application Movement Analysis
4.2. Therapeutics
4.2.1. Therapeutics Market, 2018 - 2030 (USD Billion)
4.3. In-vitro Diagnostics
4.3.1. In-vitro Diagnostics Market, 2018 - 2030 (USD Billion)
4.4. Drug Delivery
4.4.1. Drug Delivery Market, 2018 - 2030 (USD Billion)
4.5. In-vivo Imaging
4.5.1. In-vivo Imaging Market, 2018 - 2030 (USD Billion)
4.6. Implants
4.6.1. Implants Market, 2018 - 2030 (USD Billion)
Chapter 5. Indication Business Analysis
5.1. Nanomedicine Market: Indication Movement Analysis
5.2. Clinical Oncology
5.2.1. Clinical Oncology Market, 2018 - 2030 (USD Billion)
5.3. Infectious Diseases
5.3.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
5.4. Clinical Cardiology
5.4.1. Clinical Cardiology Market, 2018 - 2030 (USD Billion)
5.5. Orthopedics
5.5.1. Orthopedics Market, 2018 - 2030 (USD Billion)
5.6. Others
5.6.1. Other Indications Market, 2018 - 2030 (USD Billion)
Chapter 6. Molecule Type Business Analysis
6.1. Nanomedicine Market: Molecule Type Movement Analysis
6.2. Nanoparticles
6.2.1. Nanoparticles Market, 2018 - 2030 (USD Billion)
6.2.2. Metal & Metal Oxide Nanoparticles
6.2.2.1. Metal & Metal Oxide Nanoparticles Market, 2018 - 2030 (USD Billion)
6.2.3. Liposomes
6.2.3.1. Liposomes Market, 2018 - 2030 (USD Billion)
6.2.4. Polymers & Polymer Drug Conjugates
6.2.4.1. Polymers & Polymer Drug Conjugates Market, 2018 - 2030 (USD Billion)
6.2.5. Hydrogel Nanoparticles
6.2.5.1. Hydrogel Nanoparticles Market, 2018 - 2030 (USD Billion)
6.2.6. Dendrimers
6.2.6.1. Dendrimers Market, 2018 - 2030 (USD Billion)
6.2.7. Inorganic Nanoparticles
6.2.7.1. Inorganic Nanoparticles Market, 2018 - 2030 (USD Billion)
6.3. Nanoshells
6.3.1. Nanoshells Market, 2018 - 2030 (USD Billion)
6.4. Nanotubes
6.4.1. Nanotubes Market, 2018 - 2030 (USD Billion)
6.5. Nanodevices
6.5.1. Nanodevices Market, 2018 - 2030 (USD Billion)
Chapter 7. Regional Business Analysis
7.1. Nanomedicine Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Nanomedicine Market, 2018 - 2030 (USD Billion)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Nanomedicine Market, 2018 - 2030 (USD Billion)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. UK Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. Germany Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Nanomedicine Market, 2018 - 2030 (USD Billion)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. Australia Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Thailand Nanomedicine Market, 2018 - 2030 (USD Billion)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. South Korea Nanomedicine Market, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Nanomedicine Market, 2018 - 2030 (USD Billion)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Nanomedicine Market, 2018 - 2030 (USD Billion)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Nanomedicine Market, 2018 - 2030 (USD Billion)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Nanomedicine Market, 2018 - 2030 (USD Billion)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Nanomedicine Market, 2018 - 2030 (USD Billion)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Nanomedicine Market, 2018 - 2030 (USD Billion)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Nanomedicine Market, 2018 - 2030 (USD Billion)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Nanomedicine Market, 2018 - 2030 (USD Billion)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Nanomedicine Market, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Abbott Laboratories
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Combi Matrix Corporation
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Celgene Corporation
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Nano spectra Biosciences, Inc.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. GE Healthcare
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Johnson & Johnson Services, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Mallinckrodt Pharmaceuticals
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Merck & Co., Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Pfizer, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Teva Pharmaceutical Industries Ltd.
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Arrowhead Pharmaceuticals, Inc.
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
List of Tables
Table 1 Global Nanomedicine Market, By Region, 2018 - 2030 (USD Billion)
Table 2 Global Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 3 Global Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 4 Global Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 5 North America Nanomedicine Market, By Country, 2018 - 2030 (USD Billion)
Table 6 North America Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 7 North America Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 8 North America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 9 U.S. Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 10 U.S. Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 11 U.S. Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 12 Canada Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 13 Canada Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 14 Canada Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 15 Europe Nanomedicine Market, By Country, 2018 - 2030 (USD Billion)
Table 16 Europe Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 17 Europe Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 18 Europe Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 19 UK Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 20 UK Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 21 UK Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 22 Germany Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 23 Germany Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 24 Germany Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 25 France Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 26 France Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 27 France Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 28 Italy Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 29 Italy Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 30 Italy Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 31 Spain Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 32 Spain Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 33 Spain Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 34 Denmark Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 35 Denmark Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 36 Denmark Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 37 Sweden Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 38 Sweden Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 39 Sweden Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 40 Norway Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 41 Norway Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 42 Norway Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 43 Asia Pacific Nanomedicine Market, By Country, 2018 - 2030 (USD Billion)
Table 44 Asia Pacific Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 45 Asia Pacific Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 46 Asia Pacific Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 47 Japan Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 48 Japan Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 49 Japan Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 50 China Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 51 China Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 52 China Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 53 India Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 54 India Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 55 India Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 56 Australia Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 57 Australia Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 58 Australia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 59 Thailand Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 60 Thailand Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 61 Thailand Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 62 South Korea Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 63 South Korea Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 64 South Korea Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 65 Latin America Nanomedicine Market, By Country, 2018 - 2030 (USD Billion)
Table 66 Latin America Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 67 Latin America Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 68 Latin America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 69 Brazil Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 70 Brazil Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 71 Brazil Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 72 Mexico Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 73 Mexico Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 74 Mexico Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 75 Argentina Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 76 Argentina Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 77 Argentina Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 78 Middle East & Africa Nanomedicine Market, By Country, 2018 - 2030 (USD Billion)
Table 79 Middle East & Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 80 Middle East & Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 81 Middle East & Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 82 South Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 83 South Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 84 South Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 85 Saudi Arabia Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 86 Saudi Arabia Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 87 Saudi Arabia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 88 UAE Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 89 UAE Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 90 UAE Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 91 Kuwait Nanomedicine Market, By Application, 2018 - 2030 (USD Billion)
Table 92 Kuwait Nanomedicine Market, By Indication, 2018 - 2030 (USD Billion)
Table 93 Kuwait Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Billion)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Nanomedicine Market Segmentation
Figure 8 Market Snapshot, 2022
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 PESTEL Analysis
Figure 13 Porter’s Five Forces Analysis
Figure 14 Global Nanomedicine Market: Application Key Takeaways
Figure 15 Global Nanomedicine Market: Application Movement Analysis
Figure 16 Global Nanomedicine Market, For Therapeutics, 2018 - 2030 (USD Billion)
Figure 17 Global Nanomedicine Market, For In-vitro Diagnostics, 2018 - 2030 (USD Billion)
Figure 18 Global Nanomedicine Market, For Drug Delivery, 2018 - 2030 (USD Billion)
Figure 19 Global Nanomedicine Market, For In-vivo Imaging, 2018 - 2030 (USD Billion)
Figure 20 Global Nanomedicine Market, For Implants, 2018 - 2030 (USD Billion)
Figure 21 Global Nanomedicine Market: Indication Key Takeaways
Figure 22 Global Nanomedicine Market: Indication Movement Analysis
Figure 23 Global Nanomedicine Market, For Clinical Oncology, 2018 - 2030 (USD Billion)
Figure 24 Global Nanomedicine Market, For Infectious Diseases, 2018 - 2030 (USD Billion)
Figure 25 Global Nanomedicine Market, For Clinical Cardiology, 2018 - 2030 (USD Billion)
Figure 26 Global Nanomedicine Market, For Orthopedics, 2018 - 2030 (USD Billion)
Figure 27 Global Nanomedicine Market, For Other Indications, 2018 - 2030 (USD Billion)
Figure 28 Global Nanomedicine Market: Molecule Type Key Takeaways
Figure 29 Global Nanomedicine Market: Molecule Type Movement Analysis
Figure 30 Global Nanomedicine Market, For Nanoparticles, 2018 - 2030 (USD Billion)
Figure 31 Global Nanomedicine Market, For Metal & Metal Oxide Nanoparticles, 2018 - 2030 (USD Billion)
Figure 32 Global Nanomedicine Market, For Liposomes, 2018 - 2030 (USD Billion)
Figure 33 Global Nanomedicine Market, For Polymers & Polymer Drug Conjugates, 2018 - 2030 (USD Billion)
Figure 34 Global Nanomedicine Market, For Hydrogel Nanoparticles, 2018 - 2030 (USD Billion)
Figure 35 Global Nanomedicine Market, For Dendrimers, 2018 - 2030 (USD Billion)
Figure 36 Global Nanomedicine Market, For Inorganic Nanoparticles, 2018 - 2030 (USD Billion)
Figure 37 Global Nanomedicine Market, For Nanoshells, 2018 - 2030 (USD Billion)
Figure 38 Global Nanomedicine Market, For Nanotubes, 2018 - 2030 (USD Billion)
Figure 39 Global Nanomedicine Market, For Nanodevices, 2018 - 2030 (USD Billion)
Figure 40 Regional Marketplace: Key Takeaways
Figure 41 Regional Outlook, 2022 & 2030
Figure 42 Global Nanomedicine Market: Region Movement Analysis
Figure 43 North America Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 44 U.S. Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 45 Canada Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 46 Europe Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 47 Germany Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 48 UK Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 49 France Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 50 Italy Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 51 Spain Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 52 Denmark Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 53 Sweden Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 54 Norway Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 55 Asia Pacific Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 56 Japan Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 57 China Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 58 India Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 59 Australia Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 60 South Korea Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 61 Thailand Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 62 Latin America Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 63 Brazil Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 64 Mexico Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 65 Argentina Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 66 Middle East And Africa Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 67 South Africa Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 68 Saudi Arabia Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 69 UAE Nanomedicine Market, 2018 - 2030 (USD Billion)
Figure 70 Kuwait Nanomedicine Market, 2018 - 2030 (USD Billion)

Companies Mentioned

  • Abbott Laboratories
  • Combi Matrix Corporation
  • Celgene Corporation
  • Nano spectra Biosciences, Inc.
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Arrowhead Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 174.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 410.15 Billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Nanomedicine - Global Strategic Business Report - Product Image

Nanomedicine - Global Strategic Business Report

  • Report
  • 339 Pages
  • Global
From
Global Nanomedicine Market by Molecule Type (Nanodevices, Nanoparticles, Nanoshells), Modality (Diagnostics, Treatment), Application, Indication - Forecast 2024-2030 - Product Image

Global Nanomedicine Market by Molecule Type (Nanodevices, Nanoparticles, Nanoshells), Modality (Diagnostics, Treatment), Application, Indication - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Nanomedicine - Market Insights, Competitive Landscape, and Market Forecast - 2028 - Product Image

Nanomedicine - Market Insights, Competitive Landscape, and Market Forecast - 2028

  • Report
  • 150 Pages
  • Global
From
Nanomedicine Global Market Report 2024 - Product Image

Nanomedicine Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Nanomedicine Market Report and Forecast 2023-2031 - Product Image

Global Nanomedicine Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From

About the Nanomedicine Market

Nanomedicine is a field of medical science that uses nanotechnology to diagnose, treat, and prevent diseases. It involves the use of nanoscale materials, such as nanoparticles, nanorobots, and nanosensors, to detect and treat diseases at the cellular and molecular level. Nanomedicine has the potential to revolutionize healthcare, as it can be used to target specific cells and tissues, and to deliver drugs and other treatments directly to the site of the disease. Nanomedicine is a rapidly growing field, with many companies developing new technologies and products. Examples of companies in the nanomedicine market include NanoViricides, Inc., which is developing nanomedicines to treat viral diseases, and Nanobiotix, which is developing nanomedicines to treat cancer. Other companies in the nanomedicine market include Nanobiosym, Nanospectra Biosciences, and Nanosys. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.